Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

News   Nov 28, 2017 | Original story from University of Illinois

 
Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

Pretzel's brain tumor shrank more than 40 percent after treatment with PAC-1 in a clinical trial for dogs with glioma, a brain cancer very similar to glioblastoma in humans. Credit: Photo courtesy Tim Fan

 
 
 

RELATED ARTICLES

People with Schizophrenia Account for More than 1 in 10 Suicide Cases

News

Suicide risk assessments early in the course of illness should be emphasized, researchers say.

READ MORE

Alzheimer’s Breakthrough: Brain Metals that May Drive Disease Progression Revealed

News

Understanding the impact and management of these metals could lead to more effective future therapies for Alzheimer’s.

READ MORE

Watching Stem Cells Repair Spinal Cord in Real Time

News

Clues to the reversal of brain and spine injury.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy